亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

How should immune checkpoint inhibitor myocarditis be treated?

医学 心肌炎 内科学 暴发型 不利影响 心脏病学 易普利姆玛 免疫检查点 生物标志物 肌钙蛋白 无症状的 临床试验 心力衰竭 彭布罗利珠单抗 无容量 重症监护医学 肿瘤科 免疫系统 CTLA-4号机组 随机对照试验 心肌病 癌症 肌钙蛋白T 射血分数 代理终结点 阿巴塔克普
作者
Sally Badaan,Adi Abbass,Svetlana Tov,Gil Bar‐Sela,Naiel Bisharat
出处
期刊:Cardio-oncology [BioMed Central]
卷期号:11 (1): 108-108 被引量:6
标识
DOI:10.1186/s40959-025-00404-8
摘要

Immune checkpoint inhibitors (ICIs) have significantly advanced cancer therapy. However, these therapies can disrupt immune self-tolerance, leading to immune-related adverse events, among which immune checkpoint inhibitor-related myocarditis (ICIrM) is associated with the highest mortality rates. Clinical presentation of ICIrM varies widely, ranging from asymptomatic cardiac biomarker elevation to fulminant heart failure. As such, uniform treatment guidelines may not be appropriate, and a personalized approach is essential. There is no universal consensus on routine screening; however, baseline ECG and echocardiography are recommended by most cardio-oncology guidelines. Serial cardiac biomarker monitoring may aid in early detection and intervention. Both cardiac troponin T and cardiac troponin I are sensitive for the diagnosis of ICIrM and prognosis of increased risk of major adverse cardiovascular events. Two diagnostic frameworks for ICIrM help clinicians in establishing diagnosis. Echocardiographic global longitudinal strain measurement provides a more sensitive risk assessment than traditional measures like ejection fraction. Cardiac MRI plays a critical role, offering high diagnostic accuracy. Endomyocardial biopsy confirms ICIrM and provides both diagnostic and prognostic information based on the presence or absence of myocyte necrosis. For confirmed ICIrM, corticosteroids remain the cornerstone of therapy, with high-dose regimens shown to reduce major adverse cardiovascular events. In steroid-refractory or severe cases, adjunctive immunomodulators such as mycophenolate mofetil, janus kinase inhibitors, and notably abatacept are utilized, although evidence is largely case-based. Abatacept, a CTLA-4 fusion protein, is the only drug under investigation in a randomized trial as a targeted therapy for ICIrM. In conclusion, ICIrM represents a diagnostic and therapeutic challenge due to its rarity, heterogeneous presentation, and the limitations of current tools. By describing the management of three illustrative real-life cases, this article aims to provide a framework for individualized management of ICIrM in adults, integrating current guidelines, literature, and clinical experience. Continued research and prospective trials are critical to refine diagnostic algorithms and improve patient outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
自然大侠完成签到,获得积分10
1秒前
1秒前
贺俊龙完成签到,获得积分10
1秒前
369ninja发布了新的文献求助200
2秒前
3秒前
贺俊龙发布了新的文献求助10
5秒前
7秒前
7秒前
在水一方的应助被mochi采纳,获得10
8秒前
10秒前
苹果派发布了新的文献求助10
11秒前
11秒前
眼睛大的向彤完成签到,获得积分10
11秒前
bkagyin的应助被虾仁芋头煲采纳,获得10
12秒前
15秒前
15秒前
16秒前
清新的初雪完成签到 ,获得积分10
17秒前
我是老大的应助被大鸣王潮采纳,获得10
17秒前
江就的应助被求学的小宸采纳,获得10
18秒前
仇剑封完成签到,获得积分10
20秒前
21秒前
21秒前
23秒前
NexusExplorer的应助被mochi采纳,获得10
24秒前
正直的爆米花完成签到 ,获得积分10
25秒前
25秒前
26秒前
大鸣王潮发布了新的文献求助10
28秒前
30秒前
30秒前
JEK发布了新的文献求助10
32秒前
33秒前
33秒前
37秒前
38秒前
科研通AI6.4的应助被小羊采纳,获得10
39秒前
斯文芷巧发布了新的文献求助10
39秒前
40秒前
41秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179717
求助须知:如何正确求助?哪些是违规求助? 9569938
关于积分的说明 21807807
捐赠科研通 7775242
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557044
邀请新用户注册赠送积分活动 2478783